Upregulation of the mitochondrial transport protein, Tim50, by mutant p53 contributes to cell growth and chemoresistance.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archives of Biochemistry and Biophysics

• Publication date

  2011-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.abb.2011.05.005PMID 21621504PMCID PMC3129659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutant p53 gain-of-function in cancer.

  2010cited by this paper
• Lung specific expression of a human mutant p53 affects cell proliferation in transgenic mice

  2008cited by this paper
• Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53

  2007cited by this paper
• Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells.

  2007cited by this paper
• Involvement of the Mitochondrial Protein Translocator Component Tim50 in Growth, Cell Proliferation and the Modulation of Respiration in Drosophila

  2007cited by this paper
• Protumorigenic overexpression of stathmin/Op18 by gain‐of‐function mutation in p53 in human hepatocarcinogenesis

  2007cited by this paper
• Mutant p53: an oncogenic transcription factor

  2007cited by this paper
• An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations.

  2007cited by this paper
• Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression

  2006cited by this paper
• Repression of the MSP/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53

  2006cited by this paper
• Tim50 Maintains the Permeability Barrier of the Mitochondrial Inner Membrane

  2006cited by this paper
• Molecular mechanism of antitumor activity of taxanes in lung cancer (Review).

  2005cited by this paper
• Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

  2005cited by this paper
• Tumor-Derived p53 Mutants Induce NF-κB2 Gene Expression

  2005cited by this paper
• Tumor-derived p53 mutants induce NF-kappaB2 gene expression.

  2005cited by this paper
• Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes

  2004cited by this paper
• Tim50, a Component of the Mitochondrial Translocator, Regulates Mitochondrial Integrity and Cell Death*

  2004cited by this paper
• Modulation of Gene Expression by Tumor-Derived p53 Mutants

  2004cited by this paper
• A Defect in the p53 Response Pathway Induced by de Novo Purine Synthesis Inhibition*

  2003cited by this paper
• Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains.

  2003cited by this paper
• Tim50, a novel component of the TIM23 preprotein translocase of mitochondria

  2003cited by this paper
• Functional cooperation and separation of translocators in protein import into mitochondria, the double-membrane bounded organelles

  2003cited by this paper
• Tim50 is a subunit of the TIM23 complex that links protein translocation across the outer and inner mitochondrial membranes.

  2002cited by this paper
• Hetero-oligomerization does not compromise ‘gain of function’ of tumor-derived p53 mutants

  2002cited by this paper
• SWI/SNF Complex Interacts with Tumor Suppressor p53 and Is Necessary for the Activation of p53-mediated Transcription*

  2002cited by this paper
• The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth.

  2001cited by this paper
• Rescuing the function of mutant p53

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Mutant p53 Cooperates with ETS and Selectively Up-regulates Human MDR1 Not MRP1*

  2001cited by this paper
• Linking Global Histone Acetylation to the Transcription Enhancement of X-chromosomal Genes in Drosophila Males*

  2001cited by this paper
• Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy

  2000cited by this paper
• p53 Regulation of G2 Checkpoint Is Retinoblastoma Protein Dependent

  2000cited by this paper
• Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.

  2000cited by this paper
• Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: relationship to treatment outcome.

  2000cited by this paper
• Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

  1999cited by this paper
• Molecular epidemiology of human cancer.

  1998cited by this paper
• `Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain

  1998cited by this paper
• Mutant p53 protein expression interferes with p53-independent apoptotic pathways

  1998cited by this paper
• Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

  1996cited by this paper
• Transcriptional activation of the human epidermal growth factor receptor promoter by human p53

  1996cited by this paper
• Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma

  1995cited by this paper
• Gain of function mutations in p53

  1993cited by this paper
• Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells

  1992cited by this paper
• Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens.

  1992cited by this paper
• Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

  1992cited by this paper
• Clonal p53 mutation in primary cervical cancer: Association with human‐papillomavirus‐negative tumours

  1992cited by this paper
• Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

  1986cited by this paper

• Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells

  2025cites this paper
• Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM50

  2024cites this paper
• Lung Cancer Proteogenomics: Shaping the Future of Clinical Investigation

  2024cites this paper
• Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.

  2024cites this paper
• Androgen Receptor driven gene score identifies tumors with Epithelial to Mesenchymal Transition features in triple negative breast cancer

  2023cites this paper
• Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer

  2023cites this paper
• eIF5A controls mitoprotein import by relieving ribosome stalling at the TIM50 translocase mRNA

  2023cites this paper
• TP53INP2 modulates the malignant progression of colorectal cancer by reducing the inactive form of β-catenin.

  2023cites this paper
• An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancers

  2023cites this paper
• Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation

  2021cites this paper
• Diverse Functions of Tim50, a Component of the Mitochondrial Inner Membrane Protein Translocase

  2021cites this paper
• Nucleolar and spindle-associated protein 1 promotes non-small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D

  2020cites this paper
• Long non‐coding RNA LOC100133669 promotes cell proliferation in oesophageal squamous cell carcinoma

  2020cites this paper
• TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non‐small cell lung cancer patients

  2019cites this paper
• The Cross Talk between TbTim50 and PIP39, Two Aspartate-Based Protein Phosphatases, Maintains Cellular Homeostasis in Trypanosoma brucei

  2019cites this paper
• Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma

  2018cites this paper
• Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics.

  2017cites this paper
• The complexities of human mitochondrial inner-membrane protein translocases in maintenance of organeller function

  2017cites this paper
• Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.

  2017cites this paper
• p53 in Head and Neck Squamous Cell Carcinoma

  2017cites this paper
• Tim29 is a novel subunit of the human TIM22 translocase and is involved in complex assembly and stability

  2016cites this paper
• Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage

  2015cites this paper
• Changes in immunoexpression of p53, Ki-67, Ets-1, APAF-1 and PTEN in serrated and conventional colon adenomas.

  2015cites this paper
• Biogenesis of mitochondrial outer membrane proteins, problems and diseases

  2015cites this paper
• Mitochondrial protein translocases for survival and wellbeing

  2014cites this paper
• Transcriptional regulation by mutant p53 and oncogenesis.

  2014cites this paper
• Mutant p53 and the response to chemotherapy and radiation.

  2014cites this paper
• Oxidative stress, redox signaling and cancer chemoresistance: putting together the pieces of the puzzle.

  2014cites this paper
• p53 in DNA Damage, Repair and Cancer Therapeutics

  2013cites this paper
• The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer

  2013cites this paper
• Identification of novel mutant p53 interacting proteins by proteomic analysis.

  2013cites this paper
• p53 mutants induce transcription of NF-κB2 in H1299 cells through CBP and STAT binding on the NF-κB2 promoter and gain of function activity.

  2012cites this paper
• Mutant p53 cooperates with ETS2 to promote etoposide resistance.

  2012cites this paper
• Mechanisms of Chemoresistance in Human Ovarian Cancer at a Glance

  2012cites this paper
• Tim50 in Trypanosoma brucei Possesses a Dual Specificity Phosphatase Activity and Is Critical for Mitochondrial Protein Import*

  2012cites this paper
• Mutant p53: one name, many proteins.

  2012cites this paper